Addressing clinical development challenges amidst COVID-19

Things to consider when establishing R&D priorities as the world addresses the COVID-19 crisis There is no doubt that the current public health crisis of COVID-19 is impacting the clinical research world. In the months since it was discovered, dozens of clinical trials aimed at treating, diagnosing and preventing COVID-19 and SARS-CoV-2 have been [...]

Addressing clinical development challenges amidst COVID-192020-10-06T01:23:29-05:00

Making Strides in Women’s Health

This #CTD2019, there is much to celebrate. A guest blog by Dr. Sheryl A. Kingsberg, PhD, IF Chief, Division of Behavioral Medicine, Department of OB/GYN, MacDonald Women’s Hospital Professor, Departments of Reproductive Biology and Psychiatry, Case Western Reserve University School of Medicine Clinical Trials Day, on May 20, is an opportunity for our industry to [...]

Making Strides in Women’s Health2020-10-06T01:50:54-05:00

Clinical Trials Day

Celebrating the faces behind our women’s health research When Jacqueline Benton graduated from North Carolina’s Meredith College in 2018 she knew she wanted to work in the medical field and she knew that she wanted to help women. But the details were still a little fuzzy. Then she saw a job posting at Health Decisions for [...]

Clinical Trials Day2020-10-06T01:57:07-05:00

Considerations for Measuring Pain in Clinical Trials

From March 7-10 in Atlanta, GA, advocates, researchers and other representatives from the healthcare industry will meet to discuss the latest in women’s sexual health at the Joint International Society for the Study of Women's Sexual Health (ISSWSH) and International Society for Sexual Medicine (ISSM) Meeting. This year, several presentations will focus on the significant [...]

Considerations for Measuring Pain in Clinical Trials2020-10-06T02:05:35-05:00

Patient Advocacy Groups and Clinical Trials: Impressions from DIA 2018

The Health Decisions team at DIA 2018 left with the impression that the biopharma industry values relationships with patient advocacy groups but use of such groups in study planning and protocol development remains the exception rather than the rule. Health Decisions' Chief Medical Officer Andrea Lukes, MD, MHSc, FACOG, chaired a DIA forum entitled "From [...]

Patient Advocacy Groups and Clinical Trials: Impressions from DIA 20182020-10-06T02:21:31-05:00

The HealthyWomen Dinner: The Difference Between Men and Women in Clinical Research

Health Decisions was pleased to participate in the 2018 HealthyWomen dinner, held at the Italian Embassy in Washington June 13, where the theme was "'Alla Nostra Salute! To Our Health' - Celebrating innovation that advances women's health research and advocacy for future generations." HealthyWomen is an independent nonprofit organization addressing one of many underserved needs in [...]

The HealthyWomen Dinner: The Difference Between Men and Women in Clinical Research2020-10-06T02:22:30-05:00

CEO Takeaways from BIO 2018: Focus on Women’s Health

Health Decisions CEO, Patrick Phillips, BSc (Hons), D.Phil., attended BIO 2018 in Boston to meet with companies active in development of new therapeutic and diagnostic products to improve healthcare outcomes for women. After the conference, Dr. Phillips offered observations on a variety of trends in evidence at the conference and on Boston as a conference [...]

CEO Takeaways from BIO 2018: Focus on Women’s Health2020-10-06T02:23:55-05:00

BIO 2018: Time to Focus on Women’s Significant Unmet Medical Needs

The BIO International Convention convenes June 4 in Boston, MA. The City-on-a-Hill is an excellent setting for BIO for reasons including its role as a hotbed of both academic and commercial development. As a women’s health specialty CRO, Health Decisions sees another reason to appreciate Boston as a venue for BIO: the city’s history of [...]

BIO 2018: Time to Focus on Women’s Significant Unmet Medical Needs2020-02-20T15:59:36-05:00

Webinar: Regulatory Changes and Operational Challenges for Dx Developers

Health Decisions is offering a complimentary webinar December 14, 2017 to assist diagnostics developers in addressing regulatory changes on both sides of the Atlantic and key operational issues such as the transition to subject-based testing. Changes at FDA include faster turnaround times for some diagnostics reviews. In the EU, new Device Directives will require developers [...]

Webinar: Regulatory Changes and Operational Challenges for Dx Developers2020-10-06T03:17:05-05:00

Health Decisions to Exhibit and Present at DIA 2016

On the eve of the 2016 Drug Industry Association 52nd Annual Meeting in Philadephia June 26-30, the Health Decisions event team is looking forward to lively discussions of clinical development issues in booth #1143, a busy calendar of meetings with current and prospective clients and leading a forum on one of the hottest issues in [...]

Health Decisions to Exhibit and Present at DIA 20162020-10-06T03:29:21-05:00
Load More Posts
Go to Top